-
Cephalon Inc. et al v. Mylan Pharmaceuticals Inc. et al DC CAFC
- 1:11-cv-00164
- D. Del.
- Judge: Sue L. Robinson
- Filed: 02/24/2011
- Closed: 07/23/2013
- Latest Docket Entry: 11/12/2015
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
4
Patents-in-Suit
881
Days in
Litigation
-
Cephalon Inc. et al v. Mylan Pharmaceuticals Inc. et al DC CAFC
- 1:11-cv-00164
- D. Del.
- Judge: Sue L. Robinson
- Filed: 02/24/2011
- Closed: 07/23/2013
- Latest Docket Entry: 11/12/2015
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Mylan Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 300 mcg generic fentanyl citrate bucal tabletsFentanyl buccal tablets containing 0.3 mg of fentanyl citrate | US 6,200,604 B1 |
1, 2, 3, 11, 12
|
Infringement
Entry 170Entry 168 |
| 300 mcg generic fentanyl citrate bucal tabletsFentanyl buccal tablets containing 0.3 mg of fentanyl citrate | US 6,974,590 B2 |
1, 2, 7
|
Infringement
Entry 170Entry 168 |
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 300 mcg generic fentanyl citrate bucal tabletsFentanyl buccal tablets containing 0.3 mg of fentanyl citrate | US 6,200,604 B1 |
1, 2, 3, 11, 12
|
Infringement
Entry 170Entry 168 |
| 300 mcg generic fentanyl citrate bucal tabletsFentanyl buccal tablets containing 0.3 mg of fentanyl citrate | US 6,974,590 B2 |
1, 2, 7
|
Infringement
Entry 170Entry 168 |
